You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced esophageal squamous cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

Not yet recruiting
  • Advanced Esophageal Squamous Carcinoma With Oligometastases
  • simultaneous with radiotherapy
  • synchronous with radiotherapy
  • (no location specified)
Nov 16, 2023

The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

Recruiting
  • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
  • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
  • Hanzhou, Zhejiang, China
    Lulu Liu
Jul 14, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Intensity-modulated radiotherapy (IMRT)
  • +3 more
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jun 16, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Esophageal Squamous Cell Carcinoma Trial in Anyang, Zhengzhou (AK104, nab-paclitaxel, carboplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • AK104, nab-paclitaxel, carboplatin
  • Anyang, Henan, China
  • +1 more
Jun 1, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 30, 2023

Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

Not yet recruiting
  • Esophageal Carcinoma
  • Immune Checkpoint Inhibitors
  • (no location specified)
Jul 6, 2023

Esophageal Squamous Cell Carcinoma Trial in Beijing (Fruquintinib in Combination with S-1)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Fruquintinib in Combination with S-1
  • Beijing, China
    Peking Union Medical College Hospital
Dec 2, 2022

PFS Trial (Decitabine Injection, tirelizumab)

Not yet recruiting
  • PFS
  • (no location specified)
Nov 24, 2022

Metastatic Esophageal Squamous Cell Carcinoma Trial in Shanghai (Radiotherapy)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Radiotherapy
  • Shanghai, China
    Fudan University Shanghai cancer center
Feb 27, 2023

Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Tiragolumab)

Not yet recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 23, 2023

Esophageal Squamous Cell Carcinoma Trial (AK104)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2022

Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (Sintilimab)

Active, not recruiting
  • Esophageal Squamous Cell Carcinoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 8, 2022

Advanced Esophageal Squamous Cell Carcinoma Trial in China (TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin,

Not yet recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin
  • +2 more
  • Tongling, Anhui, China
  • +9 more
Apr 18, 2023

Esophageal Carcinoma Trial in Tianjin (camrelizumab)

Recruiting
  • Esophageal Carcinoma
  • Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jul 25, 2022

Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

Not yet recruiting
  • Esophagus Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Nov 20, 2023

Resectable Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Esophageal arterial infusion chemo, Systemic intravenous

Not yet recruiting
  • Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
  • Esophageal arterial infusion chemotherapy
  • Systemic intravenous chemotherapy
  • (no location specified)
May 15, 2022

Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

Recruiting
  • Esophagus Cancer
  • Xiamen, Fujian, China
    ShanghaiZhongshan
Apr 8, 2023

Local Advanced Esophageal Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai cancer center
    Jun 16, 2022

    Esophageal Squamous Cell Carcinoma Trial in Taipei City (Pembrolizumab)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Taipei City, Taiwan
      National Taiwan University Hospital
    Jun 5, 2022

    Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2)，Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy， distant lymph node 0.5Gy*4)
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Dec 6, 2022

    Esophageal Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab, Carboplatin or Cisplatin, Docetaxel)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Mar 30, 2022

    Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)

    Recruiting
    • Advanced Esophageal Squamous Cell Carcinoma
    • Beijing, China
    • +2 more
    Apr 6, 2023

    Squamous Cell Esophageal Carcinoma, Esophageal Cancer, Oesophageal Cancer Trial in Guangzhou (drug, radiation, procedure)

    Recruiting
    • Squamous Cell Esophageal Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 11, 2022

    Esophageal Squamous Cell Carcinoma Trial (QL1706)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Aug 4, 2022